Table 3.

Immunoreactive GPIIb-IIIa fragment, human leukocyte antigen class II restriction, T-cell helper activity inducing anti–GPIIb-IIIa antibody production, and cytokine profiles in GPIIb-IIIa–reactive CD4+ T-cell lines generated from patients with immune thrombocytopenic purpura

LineDonorImmunoreactive fragmentHLA
class II restriction
Anti-GPIIb-IIIa antibody in culture (OD450)3-150Cytokine level in culture
(pg/mL)3-151
With immunoreactive fragmentWith GST
No treatment+Platelets3-152IFN-γIL-4IL-6
FS4 ITP8 IIbα18-259 HLA-DR 0.267 0.055 0.029 256 < 1 360 
SiM4 ITP14 IIbα18-259 HLA-DR 0.351 0.101 0.048 456 296 
SuM7 ITP25 IIbα566-841 HLA-DR 0.042 0.039 0.011 780 76 18 
WY3 ITP10 IIIa22-262 HLA-DR 0.422 0.084 0.096 NT NT NT 
WY5 ITP10 IIIa22-262 HLA-DR NT NT NT NT NT NT 
WY9 ITP10 IIIa22-262 HLA-DR, -DP 0.567 0.109 0.124 280 86 567 
NE4 ITP24 IIIa22-262 HLA-DR 0.196 NT 0.014 892 16 117 
SuM8 ITP25 IIIa22-262 HLA-DR 0.397 0.051 0.017 667 67 396 
LineDonorImmunoreactive fragmentHLA
class II restriction
Anti-GPIIb-IIIa antibody in culture (OD450)3-150Cytokine level in culture
(pg/mL)3-151
With immunoreactive fragmentWith GST
No treatment+Platelets3-152IFN-γIL-4IL-6
FS4 ITP8 IIbα18-259 HLA-DR 0.267 0.055 0.029 256 < 1 360 
SiM4 ITP14 IIbα18-259 HLA-DR 0.351 0.101 0.048 456 296 
SuM7 ITP25 IIbα566-841 HLA-DR 0.042 0.039 0.011 780 76 18 
WY3 ITP10 IIIa22-262 HLA-DR 0.422 0.084 0.096 NT NT NT 
WY5 ITP10 IIIa22-262 HLA-DR NT NT NT NT NT NT 
WY9 ITP10 IIIa22-262 HLA-DR, -DP 0.567 0.109 0.124 280 86 567 
NE4 ITP24 IIIa22-262 HLA-DR 0.196 NT 0.014 892 16 117 
SuM8 ITP25 IIIa22-262 HLA-DR 0.397 0.051 0.017 667 67 396 

See Table 1 for abbreviations.

F3-150

T-cell lines were cultured with autologous peripheral blood B cells in the presence of the immunoreactive GPIIb-IIIa fragment or GST for 10 days, and anti–GPIIb-IIIa antibody levels in culture supernatants were measured by ELISA.

F3-151

T-cell lines were stimulated with phytohemagglutinin and anti-CD3 mAb for 3 days, and cytokine levels in culture supernatants were measured by ELISA.

F3-152

Culture supernatants were incubated with normal platelets before being applied to anti–GPIIb-IIIa antibody ELISA.

Close Modal

or Create an Account

Close Modal
Close Modal